PH12018501311A1 - A delayed release drug formulation - Google Patents

A delayed release drug formulation

Info

Publication number
PH12018501311A1
PH12018501311A1 PH12018501311A PH12018501311A PH12018501311A1 PH 12018501311 A1 PH12018501311 A1 PH 12018501311A1 PH 12018501311 A PH12018501311 A PH 12018501311A PH 12018501311 A PH12018501311 A PH 12018501311A PH 12018501311 A1 PH12018501311 A1 PH 12018501311A1
Authority
PH
Philippines
Prior art keywords
polymeric material
drug
core
layer
inner layer
Prior art date
Application number
PH12018501311A
Inventor
Gonzalez Roberto Carlos Bravo
Thomas Buser
Fr‚D‚Ric Jean-Claude Goutte
Abdul Waseh Basit
Felipe Jos‚ Oliveria Varum
Ana Cristina Freire
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12166110.2A external-priority patent/EP2659881B1/en
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of PH12018501311A1 publication Critical patent/PH12018501311A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and the coating comprises an outer layer and at least one layer between the core and the outer layer selected from the group consisting of an isolation layer and an inner layer. The outer layer comprises a mixture of a first polymeric material which is susceptible to attack by colonic bacteria, and a second polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a third polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said third polymeric material being selected from an at least partially neutralised polycarboxylic acid and a non-ionic polymer. In embodiments in which the third polymeric material is a non-ionic polymer, the inner layer comprises at least one of a buffer agent and a base. The isolation layer comprises a non-ionic polymer which is soluble in intestinal fluid or gastrointestinal fluid. The outer is applied directly to the inner layer or the isolation layer using a coating preparation formed by combining the first polymeric material in an aqueous medium with a second polymeric material in an organic medium. Advantages of formulations according to the present invention include accelerated release of the drug when exposed to colonic conditions and reduction or elimination of a food and/or alcohol effect on drug release after administration.
PH12018501311A 2012-04-30 2018-06-19 A delayed release drug formulation PH12018501311A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261640217P 2012-04-30 2012-04-30
EP12166110.2A EP2659881B1 (en) 2012-04-30 2012-04-30 A delayed release drug formulation
PCT/EP2013/058923 WO2013164316A1 (en) 2012-04-30 2013-04-29 A delayed release drug formulation

Publications (1)

Publication Number Publication Date
PH12018501311A1 true PH12018501311A1 (en) 2020-09-14

Family

ID=54196716

Family Applications (3)

Application Number Title Priority Date Filing Date
PH12017502369A PH12017502369A1 (en) 2012-04-30 2017-12-20 A delayed release drug formulation
PH12018500304A PH12018500304B1 (en) 2012-04-30 2018-02-12 A delayed release drug formulation
PH12018501311A PH12018501311A1 (en) 2012-04-30 2018-06-19 A delayed release drug formulation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PH12017502369A PH12017502369A1 (en) 2012-04-30 2017-12-20 A delayed release drug formulation
PH12018500304A PH12018500304B1 (en) 2012-04-30 2018-02-12 A delayed release drug formulation

Country Status (10)

Country Link
JP (2) JP6626470B2 (en)
CL (2) CL2017001989A1 (en)
CU (2) CU24343B1 (en)
CY (1) CY1121470T1 (en)
EC (2) ECSP14028079A (en)
HK (3) HK1202267A1 (en)
HR (3) HRP20190470T1 (en)
IL (2) IL235283A (en)
PH (3) PH12017502369A1 (en)
ZA (1) ZA201407675B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3662900A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662902A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
CN113493220A (en) * 2020-04-02 2021-10-12 杨洋 Hollow metal oxide microsphere, preparation method thereof and drug sustained-release application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422121A (en) * 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
WO2008135090A1 (en) * 2007-05-07 2008-11-13 Evonik Röhm Gmbh Solid dosage forms comprising an enteric coating with accelerated drug release
ES2655622T3 (en) * 2012-04-30 2018-02-20 Tillotts Pharma Ag A delayed release drug formulation

Also Published As

Publication number Publication date
PH12018500304A1 (en) 2018-09-24
HRP20190727T1 (en) 2019-06-14
JP2017145267A (en) 2017-08-24
HRP20190470T1 (en) 2019-05-17
JP6700220B2 (en) 2020-05-27
JP6626470B2 (en) 2019-12-25
PH12017502369A1 (en) 2020-09-28
CU20160026A7 (en) 2016-05-30
PH12018500304B1 (en) 2018-09-24
CL2017001990A1 (en) 2018-03-16
CU20160014A7 (en) 2016-04-25
HRP20192210T1 (en) 2020-02-21
JP2017145268A (en) 2017-08-24
HK1202267A1 (en) 2015-09-25
ECSP14028079A (en) 2015-12-31
CU24342B1 (en) 2018-05-08
CY1121470T1 (en) 2020-05-29
ZA201407675B (en) 2016-05-25
IL235282A (en) 2017-09-28
CU24343B1 (en) 2018-05-08
HK1244435B (en) 2019-10-25
ECSP14028077A (en) 2015-12-31
CL2017001989A1 (en) 2018-03-16
IL235283A (en) 2017-09-28
HK1202266A1 (en) 2015-09-25

Similar Documents

Publication Publication Date Title
JOP20200147B1 (en) A delayed release drug formulation
UA117260C2 (en) A delayed release drug formulation
PH12018501311A1 (en) A delayed release drug formulation
CU24302B1 (en) FORMULATION OF DELAYED RELEASE DRUG